Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GTF2H2C_2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZP1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
VPS13D - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
NMNAT1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
ZDBF2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
TCF7L2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
WHSC1L1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
TPGS2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
SLC44A4 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
MUC1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
B9D2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
UBA2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
LOC101929036 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
ST3GAL3 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
RPS14 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
AGBL3 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
RPL13P5 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
DPY19L4 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
YTHDC2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
THRA - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on